Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mark C. Petrie
Heart Failure With Reduced Ejection Fraction: Comparison of Patient Characteristics and Clinical Outcomes Within Asia and Between Asia, Europe and the Americas
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Is Heart Rate a Risk Marker in Patients With Chronic Heart Failure and Concomitant Atrial Fibrillation? Results From the MAGGIC Meta-Analysis
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Insulin Treatment and Clinical Outcomes in Patients With Diabetes and Heart Failure With Preserved Ejection Fraction
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Redefining Heart Failure Phenotypes Based on Ejection Fraction
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Empagliflozin Reduces the Risk of a Broad Spectrum of Heart Failure Outcomes Regardless of Heart Failure Status at Baseline
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
European Society of Cardiology/Heart Failure Association Position Paper on the Role and Safety of New Glucose‐lowering Drugs in Patients With Heart Failure
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Clinical Characteristics and Outcomes of Patients With Coronary Artery Disease and AnginaCLINICAL PERSPECTIVE
Circulation. Heart failure
Medicine
Cardiovascular Medicine
Cardiology
How Small Is Too Small? A Systematic Review of Center Volume and Outcome After Cardiac Transplantation
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Efficacy and Safety of Digoxin in Patients With Heart Failure and Reduced Ejection Fraction According to Diabetes Status: An Analysis of the Digitalis Investigation Group (DIG) Trial
International Journal of Cardiology
Cardiovascular Medicine
Cardiology
Fractional Flow Reserve (FFR) Versus Angiography in Guiding Management to Optimise Outcomes in Non-St Segment Elevation Myocardial Infarction (FAMOUS-NSTEMI) Developmental Trial: Cost-Effectiveness Using a Mixed Trial- And Model-Based Methods
Cost Effectiveness and Resource Allocation
Health Policy
